These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9804513)

  • 21. Fibrin-specific thrombolytic agents.
    Collen D
    Ann Biol Clin (Paris); 1988; 46(3):195-200. PubMed ID: 3044205
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of clot lysis in vitro and in vivo with a bispecific monoclonal antibody directed against human fibrin and against urokinase-type plasminogen activator.
    Kurokawa T; Iwasa S; Kakinuma A; Stassen JM; Lijnen HR; Collen D
    Thromb Haemost; 1991 Dec; 66(6):684-93. PubMed ID: 1796414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of heparin and epsilon-aminocaproic acid in dogs on plasmin-125-I generation in response to urokinase injections and venous injury.
    Takeda Y; Parkhill TR; Nakabayashi M
    J Clin Invest; 1972 Oct; 51(10):2678-85. PubMed ID: 4262519
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombolytic therapy.
    Collen D; Stump DC; Gold HK
    Annu Rev Med; 1988; 39():405-23. PubMed ID: 3130773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [New methods of thrombolysis].
    Vinazzer H
    Wien Med Wochenschr; 1987 Jun; 137(10-11):221-4. PubMed ID: 2955574
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of fibrin-targeting on clot lysis with urokinase-type plasminogen activator.
    Lijnen HR; Dewerchin M; De Cock F; Collen D
    Thromb Res; 1990 Feb; 57(3):333-42. PubMed ID: 2107593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombolytic agents.
    Collen D; Lijnen HR
    Thromb Haemost; 2005 Apr; 93(4):627-30. PubMed ID: 15841305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serial changes in coagulant activities after thrombolytic therapy for acute myocardial infarction.
    Goto S; Kawai Y; Abe S; Takahashi E; Handa S; Ogawa S; Watanabe K; Hori S; Ikeda Y
    Angiology; 1994 Apr; 45(4):273-81. PubMed ID: 8161005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombolytic and pharmacokinetic properties of chimeric tissue-type and urokinase-type plasminogen activators.
    Collen D; Lu HR; Lijnen HR; Nelles L; Stassen JM
    Circulation; 1991 Sep; 84(3):1216-34. PubMed ID: 1909220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
    Collen D; Lijnen HR
    Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coronary thrombolysis with clot-selective plasminogen activators.
    Collen D; Bounameaux H
    Herz; 1986 Feb; 11(1):9-15. PubMed ID: 3082731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
    GUSTO investigators
    N Engl J Med; 1993 Sep; 329(10):673-82. PubMed ID: 8204123
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Loco-regional thrombolysis in deep venous thrombosis].
    Palombo D; Porta C; Brustia P; Peinetti F; Udini M; Antico A; Maione M; Meloni T; Carbonato P
    Phlebologie; 1993; 46(2):293-302. PubMed ID: 8362012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience.
    Sloan MA; Price TR; Petito CK; Randall AM; Solomon RE; Terrin ML; Gore J; Collen D; Kleiman N; Feit F
    Neurology; 1995 Apr; 45(4):649-58. PubMed ID: 7723950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Mechanism of thrombolytic enzymes].
    Matsuo O
    Rinsho Ketsueki; 1993 Apr; 34(4):395-402. PubMed ID: 8510325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety of thrombolytic therapy in elderly patients with massive pulmonary embolism: a comparison with nonelderly patients.
    Meneveau N; Bassand JP; Schiele F; Bouras Y; Anguenot T; Bernard Y; Schultz R
    J Am Coll Cardiol; 1993 Oct; 22(4):1075-9. PubMed ID: 8409043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of impact of early catheterization and fibrin specificity on bleeding complications after thrombolytic therapy. The TAMI Study Group.
    Wall TC; Califf RM; Ellis SG; Sigmon K; Kereiakes D; George BS; Samaha J; Sane D; Stump DC; Stack RS
    J Am Coll Cardiol; 1993 Mar; 21(3):597-603. PubMed ID: 8436740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly-
    Chen S; Liang M; Wu C; Zhang X; Wang Y; Zhao M
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fibrin-specific thrombolytic agents.
    Collen D
    Schweiz Med Wochenschr; 1987 Nov; 117(46):1791-8. PubMed ID: 3122317
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.